Diagnosis and management of aspergillosis in the Netherlands: a national survey

Autor: Martha T. van der Beek, Caspar J. Hodiamont, Sabine C. de Greeff, Els de Brauwer, Ed J. Kuijper, Bart J. A. Rijnders, Eveline Roelofsen, Cees M. Verduin, Paul E. Verweij, Jacques F. Meis, Wouter Rozemeijer, E.M. Terveer, Anouk E. Muller, Maurice J.H.M. Wolfhagen, Mathijs Tersmette, Pieter Jan Haas, Tjalling Leenstra, Karin van Dijk, Willem J. G. Melchers, Astrid M. L. Oude Lashof, Jan P. Arends, Pieter P. A. Lestrade
Přispěvatelé: Medical Microbiology and Infection Prevention, Graduate School, Infectious diseases, Medical Microbiology & Infectious Diseases, Medische Microbiologie, MUMC+: DA MMI Staf (9), RS: FHML non-thematic output, Interne Geneeskunde
Rok vydání: 2016
Předmět:
MECHANISM
0301 basic medicine
medicine.medical_specialty
Antifungal Agents
TRIAZOLE RESISTANCE
030106 microbiology
lnfectious Diseases and Global Health Radboud Institute for Molecular Life Sciences [Radboudumc 4]
Azole resistance
Dermatology
FREQUENCY
Aspergillosis
Aspergillus fumigatus
03 medical and health sciences
azole resistance
Drug Resistance
Fungal
Amphotericin B
Surveys and Questionnaires
Internal medicine
SURVEILLANCE
medicine
Humans
University medical
TR34/L98H MUTATIONS
Intensive care medicine
Netherlands
Voriconazole
ENVIRONMENT
Women's cancers Radboud Institute for Molecular Life Sciences [Radboudumc 17]
FUMIGATUS
treatment
biology
business.industry
STRAINS
Hospital level
General Medicine
biology.organism_classification
medicine.disease
PREVALENCE
lnfectious Diseases and Global Health Radboud Institute for Health Sciences [Radboudumc 4]
Infectious Diseases
Liposomal amphotericin
business
medicine.drug
Zdroj: Lestrade, P P A, Meis, J F, Arends, J P, van der Beek, M T, de Brauwer, E, van Dijk, K, de Greeff, S C, Haas, P J, Hodiamont, C J, Kuijper, E J, Leenstra, T, Muller, A E, Oude Lashof, A M L, Rijnders, B J, Roelofsen, E, Rozemeijer, W, Tersmette, M, Terveer, E M, Verduin, C M, Wolfhagen, M J H M, Melchers, W J G & Verweij, P E 2016, ' Diagnosis and management of aspergillosis in the Netherlands : A national survey ', Mycoses, vol. 59, no. 2, pp. 101-107 . https://doi.org/10.1111/myc.12440
Mycoses, 59(2), 101-107. Wiley-Blackwell
Mycoses, 59, 101-7
Mycoses, 59(2), 101-107. Wiley
Mycoses, 59(2), 101-107. Wiley-Blackwell Publishing Ltd
Mycoses, 59(2), 101-107. WILEY-BLACKWELL
Mycoses, 59, 2, pp. 101-7
ISSN: 0933-7407
DOI: 10.1111/myc.12440
Popis: Contains fulltext : 172306.pdf (Publisher’s version ) (Closed access) A survey of diagnosis and treatment of invasive aspergillosis was conducted in eight University Medical Centers (UMCs) and eight non-academic teaching hospitals in the Netherlands. Against a background of emerging azole resistance in Aspergillus fumigatus routine resistance screening of clinical isolates was performed primarily in the UMCs. Azole resistance rates at the hospital level varied between 5% and 10%, although rates up to 30% were reported in high-risk wards. Voriconazole remained first choice for invasive aspergillosis in 13 out of 16 hospitals. In documented azole resistance 14 out of 16 centres treated patients with liposomal amphotericin B.
Databáze: OpenAIRE
Externí odkaz: